货号:A423786
同义名:
RU 38486; RU486
Mifepristone is an antagonist of progesterone receptor (IC50 = 0.2 nM) and glucocorticoid receptor (IC50 = 2.6 nM).
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | Mifepristone (RU486) acts as an antagonist for both progesterone receptor (PR) and glucocorticoid receptor (GR), displaying IC50 values of 0.2 nM and 2.6 nM, respectively, in in vitro assays[1]. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
A549 cells | Function assay | Antagonist activity at human glucocorticoid receptor assessed as inhibition of corticoid-induced transcription in human A549 cells by GRE-linked luciferase reporter gene assay, IC50=0.0016 μM | 17317167 | ||
A549 cells | Function assay | 16 h | Antagonist activity at glucocorticoid receptor in human A549 cells assessed as inhibition of corticoid-induced transcription after 16 hrs by glucocorticoid response element-driven luciferase reporter gene assay, IC50=0.0016 μM | 19217285 | |
CHO cells | Function assay | Inhibition of Dexamethasone stimulated transcriptional activity in CHO cells expressing glucocorticoid receptor, IC50=0.005 μM | 12824023 | ||
CHO-K1 cells | Function assay | Inhibition of CHO-K1 cells expressing glucocorticoid receptor, IC50=8e-06 μM | 15456242 | ||
Animal study | In cervix tumor xenograft models treated with NSC 119875 alone, there is notable tumor growth inhibition compared to the control group. However, combining NSC 119875 with Mifepristone results in even more significant tumor weight reduction (p<0.05), achieving approximately a 50% decrease compared to individual treatments by the study's end[2].Adult male Sprague-Dawley rats undergo a 4-day binge-like ethanol (EtOH) administration regimen (3 to 5 g/kg, orally, every 8 hours), aimed at achieving peak blood EtOH levels (BELs) under 300 mg/dL. Subgroups of these animals receive subcutaneous injections of Mifepristone (20 or 40 mg/kg in peanut oil). While Mifepristone does not significantly alter the behavior of EtOH-naïve animals, pretreatment with Mifepristone (40 mg/kg) significantly reduces the severity of EtOH withdrawal. There is a notable interaction between diet and drug, F(5,55)=3.92, p<0.05, showing that EtOH-treated animals receiving either the vehicle or 20 mg/kg of Mifepristone exhibit significantly more signs of EtOH withdrawal compared to EtOH-naïve animals undergoing the same treatment. Crucially, 40 mg/kg of Mife |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01419535 | Endocrine Disease ... 展开 >> Diabetes 收起 << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01898312 | Women With Mutations in the Br... 展开 >>east Cancer Susceptibility Genes BRCA1,2 收起 << | Phase 2 | Recruiting | December 2018 | Sweden ... 展开 >> Department of Woman and Child Health Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Sub-Investigator: Angelique Flöter Rådestad, MD PhD 收起 << |
NCT00382538 | Abortion, Induced ... 展开 >> Abortion, Second Trimester 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Boston Medical Center Boston, Massachusetts, United States, 02118 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.33mL 0.47mL 0.23mL |
11.64mL 2.33mL 1.16mL |
23.28mL 4.66mL 2.33mL |
CAS号 | 84371-65-3 |
分子式 | C29H35NO2 |
分子量 | 429.59 |
SMILES Code | C[C@@]12[C@@](C#CC)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CCC4=C3[C@@H](C5=CC=C(N(C)C)C=C5)C2)=O |
MDL No. | MFCD00867226 |
别名 | RU 38486; RU486; Mifepristona; Mifepristonum; C-1073 |
运输 | 蓝冰 |
InChI Key | VKHAHZOOUSRJNA-GCNJZUOMSA-N |
Pubchem ID | 55245 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|